How big is the Hemophilia Market?

The Hemophilia Market size is expected to reach USD 14.41 billion in 2025 and grow at a CAGR of 5.5% to reach USD 18.83 billion by 2030. Read More

What is the current Hemophilia Market size?

In 2025, the Hemophilia Market size is expected to reach USD 14.41 billion. Read More

Who are the key players in Hemophilia Market?

Pfizer, Inc., Bayer AG, Novo Nordisk A/S, CSL Limited (CSL Behring) and BioMarin are the major companies operating in the Hemophilia Market. Read More

Which is the fastest growing region in Hemophilia Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030). Read More

Which region has the biggest share in Hemophilia Market?

In 2025, the North America accounts for the largest market share in Hemophilia Market. Read More

What years does this Hemophilia Market cover, and what was the market size in 2024?

In 2024, the Hemophilia Market size was estimated at USD 13.62 billion. The report covers the Hemophilia Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Hemophilia Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030. Read More

Hemophilia Companies

This report lists the top Hemophilia companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Hemophilia industry.

Hemophilia Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

About This Report
- Market Snapshot
- Market Overview
- Key Market Trends
- Competitive Landscape
- Major Players
- Recent Developments
Table of Contents
Scope of the Report
Frequently Asked Questions